Page last updated: 2024-08-05 11:00:35

organophosphate oxoanion

An organic phosphoric acid derivative in which one or more oxygen atoms of the phosphate group(s) has been deprotonated.

ChEBI ID: 58945

Members (21)

MemberDefinitionRole
1-phospho-5-s-methylthioribuloseDianion of S-methyl-5-thio-D-ribulose 1-phosphate.S-methyl-5-thio-D-ribulose 1-phosphate(2-)
3'-deoxy-3',4'-didehydro-CTP(4-)3'-deoxy-3',4'-didehydro-CTP(4-)
6-phosphogluconolactoneDianion of 6-O-phosphono-D-glucono-1,5-lactone arising from deprotonation of the phosphate OH groups; major species at pH 7.3.6-O-phosphonato-D-glucono-1,5-lactone(2-)
7-methylguanosine-5'-monophosphateAn organophosphate oxoanion arising from deprotonation of the phosphate OH groups of 7-methylguanosine 5'-phosphate; major species at pH 7.3.7-methylguanosine 5'-phosphate(1-)
adenosine thiamine triphosphateAn organophosphate oxoanion obtained by deprotonation of the triphosphate OH groups of adenosine thiamine triphosphate.adenosine thiamine triphosphate(2-)
bis(molybdopterin guanine dinucleotide)molybdenumAn organophosphate oxoanion arising from deprotonation of the four diphosphate OH groups of bis(molybdopterin guanine dinucleotide)molybdenum.bis(molybdopterin guanine dinucleotide)molybdenum(4-)
cyclic ampAn organophosphate oxoanion that is the conjugate base of 3',5'-cyclic AMP arising from deprotonation of the free phosphate OH group; major species at pH 7.3.3',5'-cyclic AMP(1-)
cytidine diphosphate cholineConjugate base of CDP-choline(1+) arising from deprotonation of the diphosphate function.CDP-choline(1-)
diadenosine tetraphosphateTetraanion of P(1),P(4)-bis(5'-adenosyl) tetraphosphate arising from deprotonation of the tetraphosphate OH groups; major species at pH 7.3.P(1),P(4)-bis(5'-adenosyl) tetraphosphate(4-)
diglycerol phosphateAn organophosphate oxoanion that is the conjugate base of glycerophosphoglycerol; major species at pH 7.3.glycerophosphoglycerol(1-)
glycinamide ribonucleotideglycinamide ribonucleotide(2-)
lipid iiiAn organophosphate oxoanion resulting from deprotonation of the carboxy and phosphate OH groups of alpha-D-FucNAc4-(1->4)-beta-D-ManNAcA-(1->4)-alpha-D-GlcNAc-undecaprenyl diphosphate; major species at pH 7.3.4)-beta-D-ManNAcA-(1->4)-D-GlcNAc-undecaprenyl-diphosphate(3-).html>alpha-D-FucNAc4-(1->4)-beta-D-ManNAcA-(1->4)-D-GlcNAc-undecaprenyl diphosphate(3-)
molybdenum cofactorAn organophosphate oxoanion obtained by deprotonation of the phosphate OH groups of MoO2-molybdopterin cofactor.MoO2-molybdopterin cofactor(2-)
nadAn anionic form of nicotinamide adenine dinucleotide arising from deprotonation of the two OH groups of the diphosphate moiety.NAD(1-)
nicotinate mononucleotideDianion of nicotinic acid D-ribonucleotide arising from deprotonation of carboxylic acid and phosphate functions.nicotinate D-ribonucleotide(2-)
p(1),p(5)-di(adenosine-5'-)pentaphosphateAn organophosphate oxoanion arising from global deprotonation of the pentaphosphate OH groups of P(1),P(5)-bis(5'-adenosyl) pentaphosphate.P(1),P(5)-bis(5'-adenosyl) pentaphosphate(5-)
phaclofenphaclofen zwitterion
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acidAn organophosphate oxoanion obtained by deprotonation of the phospho and sulfo groups of 5'-phosphopyridoxal-6-azobenzene-2,4-disulfonic acid.5'-phosphonatopyridoxal-6-azobenzene-2,4-disulfonate
thiamine pyrophosphateTrianion of thiamine(1+) diphosphate arising from deprotonation of the four OH groups of the triphosphate.thiamine(1+) triphosphate(4-)
ticrynafenTrianion of 2-phosphoglycolic acid arising from deprotonation of the carboxy and phosphate groups; major species at pH 7.3.2-phosphonatoglycolate(3-)
xylitol 5-phosphateDianion of xylitol 5-phosphate arising from deprotonation of the phosphate OH groups; major species at pH 7.3.xylitol 5-phosphate(2-)

Research

Studies (30,181)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-199015,542 (51.50)18.7374
1990's4,257 (14.10)18.2507
2000's4,082 (13.53)29.6817
2010's4,279 (14.18)24.3611
2020's2,021 (6.70)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials90 (0.29%)5.53%
Reviews1,693 (5.36%)6.00%
Case Studies138 (0.44%)4.05%
Observational8 (0.03%)0.25%
Other29,631 (93.89%)84.16%